Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound bone cement with function of reducing thermal necrosis effect

A bone cement and low-heat technology, applied in the field of materials, can solve the problems of inability to form external callus, PMMA thermal necrosis, poor mechanical strength, etc., and achieve the effects of reducing thermal necrosis, lowering the maximum temperature, and maintaining the curing rate

Active Publication Date: 2015-07-22
PEKING UNIV THIRD HOSPITAL +1
View PDF4 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, in clinical practice, the most prominent shortcoming of PMMA is that a large amount of heat is released during the polymerization process, and its maximum temperature exceeds the range that the human body can tolerate, thus causing necrosis of its surrounding tissues.
Non-physiological thermal effects will bring about many deficiencies, and ultimately lead to treatment failure: (1) During joint replacement surgery, the surrounding bone tissue is necrotic, making it impossible for PMMA to form a stable interlocking structure with the bone structure. PMMA and bone There are micro-movements between the structures, which produce a large number of PMMA particles, and long-term accumulation will form aseptic loosening; (2) During KP surgery, cancellous osteonecrosis in the vertebral body is caused, and a ring-shaped necrosis zone appears around the PMMA. The mechanical strength of this area Poor, not only easy to cause re-collapse after fracture reduction, but also a corresponding increase in the incidence of re-fracture of the same vertebral body; (3) The catastrophic complication of KP is that PMMA enters the spinal canal and damages the nerves, and the pathogenic factors of the injury are other than In addition to mechanical extrusion, thermal burns play an important role; (4) When cement augmentation is used in fracture surgery, it will cause periosteal necrosis on the outer surface of the cortical bone, and the outer callus cannot be formed, eventually resulting in delayed union or nonunion of the fracture
Therefore, there is an urgent need to solve the problem of thermal necrosis caused by PMMA in clinical practice.
[0005] Phase change materials have the characteristics of absorbing a large amount of heat without increasing the temperature during the phase change process. As cooling energy storage materials, they have been widely used in construction and military fields, but there are no relevant reports in medical materials.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound bone cement with function of reducing thermal necrosis effect
  • Compound bone cement with function of reducing thermal necrosis effect
  • Compound bone cement with function of reducing thermal necrosis effect

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 Preparation and characterization of PMMA-paraffin / silica (PMMA10) bone cement

[0035]Mix 9g of currently clinically used PMMA powder (MENDECSPINE, the main components are polymethylmethacrylate 67.5wt%, barium sulfate 30wt%, and diphenyl peroxide 2.5wt%) with 1g paraffin / silica microcapsules Put it into a ball mill jar and mix at low speed for 30 minutes to obtain the solid phase components. Weigh 8g of the solid phase component and put it into a 20ml syringe, add the liquid phase component (the mass fraction of methyl methacrylate is 99.1%, the mass fraction of DMPT is 0.9%, and hydroquinone is 75ppm) to control the solid-liquid ratio 2:1 (m / v), fully stirred for 1 min, injected into the mold, and cured to obtain PMMA10 composite bone cement. Its surface morphology is as figure 1 As shown in c, it can be seen from the figure that the paraffin / silica microcapsule structure is stable and can be tightly combined with PMMA. The maximum exothermic temperature ...

Embodiment 2

[0036] Example 2 Preparation and characterization of PMMA-paraffin / silica (PMMA20) bone cement

[0037] Mix 8 g of currently clinically used PMMA powder (MENDECSPINE) and 2 g of paraffin / silicon dioxide microcapsules into a ball mill, and mix at a low speed for 30 minutes to obtain a solid phase component. Weigh 8g of the solid phase component and put it into a 20ml syringe, add the liquid phase component (the mass fraction of methyl methacrylate is 99.1%, the mass fraction of DMPT is 0.9%, and hydroquinone is 75ppm) to control the solid-liquid ratio 2:1 (m / v), fully stirred for 1 min, injected into the mold, and cured to obtain PMMA20 composite bone cement. Its surface morphology is as figure 1 As shown in d, it can be seen from the figure that the surface of the material becomes rougher, but the paraffin / silica microcapsule structure is stable and can be tightly combined with PMMA. The maximum exothermic temperature of PMMA20 bone cement during curing is 44°C, which is les...

Embodiment 3

[0038] Example 3 Preparation and characterization of PMMA-paraffin / silica (PMMA30) bone cement

[0039] Mix 7 g of currently clinically used PMMA powder (MENDECSPINE) and 3 g of paraffin / silicon dioxide microcapsules into a ball mill, and mix at a low speed for 30 minutes to obtain a solid phase component. Weigh 8g of the solid phase component and put it into a 20ml syringe, add 4ml of the liquid phase component (the mass fraction of methyl methacrylate is 99.1%, the mass fraction of DMPT is 0.9%, and hydroquinone is 75ppm) to control the solid-liquid The ratio is 1.5:1 (m / v), fully stirred for 1 min, injected into the mold, and cured to obtain PMMA30 composite bone cement. The maximum exothermic temperature during the curing process of PMMA30 bone cement was 35°C ( figure 2 a), less than the normal body temperature of the human body; curing time is 32min ( figure 2 b), the feasibility of clinical operation is poor.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
quality scoreaaaaaaaaaa
quality scoreaaaaaaaaaa
quality scoreaaaaaaaaaa
Login to View More

Abstract

The invention relates to low-heat type compound bone cement and a preparation method thereof. Raw materials of the bone cement include a solid-phase component and a liquid-phase component; the solid-phase component comprises an acrylic polymer and a phase-change microcapsule material (PCM). The preparation method of the bone cement comprises the following steps: uniformly stirring and mixing the solid-phase component and the liquid-phase component at a certain ratio, injecting a mixture into a mould, and performing curing to obtain the low-heat type compound bone cement. The compound bone cement is nontoxic and has injectable property, curing rate and mechanical property suitable for clinic; the highest temperature in a curing process is greatly reduced, so that a thermal necrosis effect can be reduced and the use safety of the acrylic polymer bone cement in a human body is improved.

Description

technical field [0001] The invention belongs to the field of materials, in particular to an acrylate-based composite bone cement with the effect of reducing thermal necrosis. Background technique [0002] As the aging population continues to intensify, osteoporotic fractures have become a difficult problem for researchers and clinicians to face. According to EU statistics in 2013, there are 3.5 million new osteoporotic fractures in the EU every year, and medical expenses are about 37 billion euros. In 2010, the National Bureau of Statistics of my country estimated that there were 80 million patients with osteoporosis in China, and about 8 million new osteoporotic fractures occurred each year. Osteoporotic fractures often require surgical treatment, and the current problems are: fractures are often comminuted, and local bone defects are easy to form; poor bone mass, internal fixation or low holding force of the prosthesis can easily lead to the loosening of the implant, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/16A61L27/50A61L24/06
Inventor 周方吕扬邱东李爱玲杨振忠
Owner PEKING UNIV THIRD HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products